Level 3: Clinical trials
Level 2: Actionable information
Version 0.9
|
review
|
Not set
|
Sources
- Expert Review Green
- ClinicalTrials.gov
Phenotypes
- Duchenne Muscular Dystrophy
Tags
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 3.17
Latest signed off version: v3.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
Not set
|
Sources
- Expert Review Red
- Eligibility statement prior genetic testing
Tags
|
Level 2: Viral research
Version 1.141
|
review
|
Not set
|
Sources
Tags
|
Level 3: Gastrointestinal disorders
Level 2: Gastroenterological disorders
Version 1.23
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- Expert Review Green
- Literature
Phenotypes
- Duchenne muscular dystrophy 310200
Tags
- gene-therapy-trial
- Skewed X-inactivation
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 3.48
Latest signed off version: v3.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- Expert Review Green
- Radboud University Medical Center, Nijmegen
- Emory Genetics Laboratory
- Illumina TruGenome Clinical Sequencing Services
- UKGTN
Phenotypes
- Becker muscular dystrophy 300376
Tags
- gene-therapy-trial
- Skewed X-inactivation
|
Version 19.202
Latest signed off version: v19.1
(22 Mar 2023)
|
review
|
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
|
Sources
Phenotypes
- Duchenne muscular dystrophy, 310200
- Becker muscular dystrophy, 300376
|
Level 3: Cardiomyopathy
Level 2: Cardiovascular disorders
Version 1.85
|
review
|
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
|
Sources
- South West GLH
- London South GLH
- Expert Review Green
- Illumina TruGenome Clinical Sequencing Services
- Expert list
- Emory Genetics Laboratory
- Radboud University Medical Center, Nijmegen
Phenotypes
- Cardiomyopathy, dilated, 3B
- Dilated Cardiomyopathy, X-Linked
Tags
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 4.23
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- NHS GMS
- Expert Review Green
- Emory Genetics Laboratory
- Radboud University Medical Center, Nijmegen
- UKGTN
Phenotypes
- Becker muscular dystrophy, OMIM:300376
- Duchenne muscular dystrophy, OMIM:310200
Tags
- gene-therapy-trial
- Skewed X-inactivation
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 5.22
Latest signed off version: v5.0
(22 Mar 2023)
|
review
|
Not set
|
Sources
- Expert Review Red
- Radboud University Medical Center, Nijmegen
- Emory Genetics Laboratory
- UKGTN
- Expert list
Phenotypes
- Duchenne muscular dystrophy, 310200Becker muscular dystrophy, 300376Cardiomyopathy, dilated, 3B, 302045
- Duchenne or Becker muscular dystrophy
Tags
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 4.32
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
|
Sources
- Expert Review Green
- Eligibility statement prior genetic testing
Phenotypes
- Duchenne muscular dystrophy 310200
- Becker muscular dystrophy 300376
Tags
- gene-therapy-trial
- Skewed X-inactivation
|
Level 3: Cardiomyopathy
Level 2: Cardiovascular disorders
Version 2.22
Latest signed off version: v2.8
(22 Mar 2023)
Component of the following Super Panels:
Sudden unexplained death or survivors of a cardiac event
|
review
|
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
|
Sources
- Expert Review Green
- Literature
- NHS GMS
Phenotypes
- Becker muscular dystrophy, 300376
- Cardiomyopathy, dilated, 3B, 302045
- Duchenne muscular dystrophy, 310200
Tags
|
Version 3.155
Latest signed off version: v3.0
(22 Mar 2023)
|
review
|
Not set
|
Sources
Tags
|
Version 3.87
Latest signed off version: v3.1
(22 Mar 2023)
Component of the following Super Panels:
Paediatric disorders
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- DD-Gene2Phenotype
- Expert Review Green
Phenotypes
- DUCHENNE MUSCULAR DYSTROPHY 310200
- BECKER MUSCULAR DYSTROPHY 300376
- CARDIOMYOPATHY DILATED X-LINKED TYPE 3B 302045
Tags
|
Level 3: Motor and Sensory Disorders of the PNS
Level 2: Neurology and neurodevelopmental disorders
Version 1.477
|
review
|
Not set
|
Sources
- NHS GMS
- South West GLH
- Emory Genetics Laboratory
Phenotypes
Tags
|
Level 3: Non-syndromic hearing loss
Level 2: Hearing and ear disorders
Version 4.38
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Paediatric disorders
|
review
|
Not set
|
Sources
Tags
|
Level 3: Neurodevelopmental disorders
Level 2: Neurology and neurodevelopmental disorders
Version 5.532
Latest signed off version: v5.0
(22 Mar 2023)
Component of the following Super Panels:
Childhood onset leukodystrophy
Hypotonic infant
Paediatric disorders
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- Victorian Clinical Genetics Services
- Expert Review Green
- Radboud University Medical Center, Nijmegen
- Emory Genetics Laboratory
Phenotypes
- Duchenne muscular dystrophy, 310200Becker muscular dystrophy, 300376Cardiomyopathy, dilated, 3B, 302045
- BECKER MUSCULAR DYSTROPHY (BMD)
Tags
- gene-therapy-trial
- Skewed X-inactivation
|
Level 3: Posterior segment abnormalities
Level 2: Ophthalmological disorders
Version 4.89
Latest signed off version: v4.0
(22 Mar 2023)
|
review
|
Not set
|
Sources
- NHS GMS
- RetNet
- Expert Review Amber
Tags
|
Version 3.46
Latest signed off version: v3.0
(22 Mar 2023)
Component of the following Super Panels:
Unexplained death in infancy and sudden unexplained death in childhood
|
review
|
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
|
Sources
- NHS GMS
- South West GLH
- Expert Review Green
Phenotypes
- Duchenne muscular dystrophy, 310200
- Dilated Cardiomyopathy, X-Linked
- Cardiomyopathy, dilated, 3B
- Becker muscular dystrophy, 300376
Tags
|
Version 3.94
Latest signed off version: v3.24
(15 May 2023)
|
review
|
Not set
|
Sources
- NHS GMS
- South West GLH
- Emory Genetics Laboratory
- NHS GMS
- South West GLH
Phenotypes
Tags
|
Version 1.184
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- Next Generation Children Project
- Expert Review Green
- Expert list
Phenotypes
- Becker muscular dystrophy, 300376
- Cardiomyopathy, dilated, 3B, 302045
- Duchenne muscular dystrophy, 310200
Tags
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 1.18
Latest signed off version: v1.7
(31 May 2023)
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- NHS GMS
- Expert Review Green
Phenotypes
- Becker muscular dystrophy, OMIM:300376
- Exercise induced crams and myoglobinuria
|
Version 1.1
Latest signed off version: v1.0
(14 Sep 2023)
|
review
|
X-LINKED: hemizygous mutation in males, biallelic mutations in females
|
Sources
- Expert Review Green
- NHS GMS
|